EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models

Milena Jovanovic, Apratim Mitra iD, Chris Stephan iD, Ka Wai Wong, Sara Talvacchio iD, Antonella Forlino iD, Michael To, Kenneth M Kozloff, Ryan K Dale, Joan C Marini

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Milena Jovanovic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section on Heritable Disorders of Bone and Extracellular Matrix, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Nat…. Hauptthemen laut MEDLINE: Osteoblasts, Osteogenesis Imperfecta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD IRP funding, Italian Ministry of Education, University and Research (MIUR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the hallmarks of Osteogenesis Imperfecta (OI) is phenotypic variability among individuals with the same mutation. The aim of our study is to investigate the under-explored role of osteoblast differentiation in OI phenotypic variability by using human and murine OI osteoblasts. This is the first comparative study of osteoblasts from OI patients vs. healthy pediatric controls. We investigated osteoblasts carrying COL1A1 substitutions Gly352Ser and Gly589Ser, each expressed in two unrelated patients differing in phenotypic severity. Osteoblasts from type III OI patients with both mutations deposited significantly less mineral vs. type IV. RNA-Seq showed osteoblasts from type IV OI patients with different mutations had downregulated mitochondrial pathways, while osteoblasts from type III OI patients showed downregulation of extracellular matrix pathways. Puromycin assay demonstrated osteoblast protein synthesis was significantly upregulated in type III vs. type IV OI patients. UPR PERK and BiP were reduced in osteoblasts with Gly352Ser from type III and IV OI patients and in osteoblasts with Gly589Ser from a type III OI patient, while both proteins were increased in Gly589Ser osteoblasts from the type IV patient. Additionally, in a murine comparative study, Col1a1 Gly349Ser, called Brtl Ser, showed a much more severe skeletal phenotype than Brtl Cys. Brtl Ser calvarial osteoblasts had reduced collagen secretion and folding with abnormal dermal collagen fibrils vs. wildtype. Also, Brtl Ser osteoblasts showed condensed actin filaments but a similar mineral deposition as Brtl Cys. Electron microscopy revealed elongated mitochondria with cristae dropout in patient and mutant murine osteoblasts. Our study yielded novel insights highlighting osteoblast differentiation, mineralization, and a potential role of mitochondria in OI pathology and phenotypic variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoblastsOsteogenesis ImperfectaAnimalsHumansMiceCollagen Type I, alpha 1 ChainCollagen Type IDisease Models, AnimalPhenotypeFemaleMaleCell DifferentiationMutationChildChild, PreschoolMitochondria

Stichwörter der Autor:innen

Osteogenesis Imperfectabone mineralizationmitochondriaosteoblast differentiationphenotypic variability

Substanzen

Collagen Type I, alpha 1 ChainCollagen Type ICOL1A1 protein, human

Autor:innen und Institutionen

  • Section on Heritable Disorders of Bone and Extracellular Matrix, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
  • Bioinformatics and Scientific Programming Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Orthopaedics and Traumatology, The University of Hong Kong-Shenzhen Hospital (HKU-SZH), Shenzhen 518053, China.
  • Department of Orthopaedics and Traumatology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Office of the Clinical Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

ORCID-Profile: Apratim Mitra, Chris Stephan, Sara Talvacchio, Antonella Forlino

Förderung

  • NICHD IRP funding
  • Italian Ministry of Education, University and Research (MIUR)

Zitieren

APA

Jovanovic, M., Mitra, A., Stephan, C., Wong, K. W., Talvacchio, S., Forlino, A., To, M., Kozloff, K. M., Dale, R. K., & Marini, J. C. (2025). The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311722

Vancouver

Jovanovic M, Mitra A, Stephan C, Wong KW, Talvacchio S, Forlino A, et al. The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311722

BibTeX
@article{Jovanovic2025,
  author = {Jovanovic, Milena and Mitra, Apratim and Stephan, Chris and Wong, Ka Wai and Talvacchio, Sara and Forlino, Antonella and To, Michael and Kozloff, Kenneth M and Dale, Ryan K and Marini, Joan C},
  title = {The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311722}
}
Kostenlos starten →